TONSL在食管癌中的表达及其影响食管鳞癌细胞增殖的机制

doi:10.3969/j.issn.1004-616x.2023.06.002

癌变·畸变·突变 ›› 2023, Vol. 35 ›› Issue (6): 412-419.doi: 10.3969/j.issn.1004-616x.2023.06.002

TONSL在食管癌中的表达及其影响食管鳞癌细胞增殖的机制

郑雅琪¹, 赵子婷², 潘德渊², 刘禄鑫¹, 许秀娥¹, 廖连娣¹, 王少洪³, 李恩民², 许丽艳¹

1. 汕头大学医学院病理教研室, 广东汕头 515041;
2. 汕头大学医学院生物化学与分子生物学教研室, 广东汕头 515041;
3. 汕头市中心医院病理科, 广东汕头 515041

收稿日期:2023-04-11 修回日期:2023-06-25 出版日期:2023-11-30 发布日期:2023-12-09
通讯作者: 李恩民;许丽艳
作者简介:郑雅琪，E-mail：1913828712@qq.com。
基金资助:
国家重点研发计划“精准医学研究”重点专项(2016YFC0901400)；2021年广东省科技专项(210729156901797)

The expression of tonsoku-like DNA repair protein in esophageal carcinoma and its effect on the proliferation of esophageal squamous cell carcinoma

ZHENG Yaqi¹, ZHAO Ziting², PAN Deyuan², LIU Luxin¹, XU Xiue¹, LIAO Liandi¹, WANG Shaohong³, LI Enmin², XU Liyan¹

1. Department of Pathology, Shantou University Medical College, Shantou 515041;
2. Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou 515041;
3. Department of Pathology, Shantou Central Hospital, Shantou 515041, Guangdong, China

Received:2023-04-11 Revised:2023-06-25 Online:2023-11-30 Published:2023-12-09

摘要/Abstract

摘要： 目的：探讨tonsoku样DNA修复蛋白(TONSL)在食管癌组织中的表达及其对食管鳞癌细胞增殖的影响及机制。方法：利用cBioPortal、GEPIA和PRIDE等数据库分析在食管癌组织中，TONSL基因组拷贝数及其转录和翻译水平的变化。通过免疫组织化学实验检测TONSL蛋白在食管鳞癌和正常食管组织中的表达。利用siRNA干扰构建TONSL瞬时敲降食管鳞癌细胞模型，并采用集落形成实验和EdU实验检测TONSL敲降对食管鳞癌细胞增殖能力的影响。Western blot检测TONSL敲降后食管鳞癌细胞中DNA损伤修复相关标志蛋白ATM丝氨酸/苏氨酸激酶(ATM)和检查点激酶2(CHK2)及其磷酸化激活水平的变化。结果：与正常食管组织比较，食管癌基因组、转录组和蛋白质组的数据库分析结果显示，TONSL在食管癌组织中拷贝数增加表达，其mRNA和蛋白质表达水平在食管癌组织中均上调(P<0.05)，且TONSL高表达与食管癌患者不良预后相关(P<0.05)；免疫组织化学验证结果也表明TONSL蛋白在食管鳞癌组织中表达上调(P<0.001)。集落形成实验和EdU实验结果显示，与对照组相比，TONSL敲降后食管鳞癌细胞增殖能力减弱(P<0.05)，并且在敲降TONSL后，食管鳞癌细胞DNA损伤修复相关蛋白ATM和CHK2的磷酸化水平均上调(均为P<0.05)。结论：TONSL在食管鳞癌中表达上调，并通过参与食管鳞癌细胞DNA损伤修复促进食管鳞癌细胞增殖。

关键词: 食管鳞癌, tonsoku样DNA修复蛋白, 细胞增殖, DNA损伤修复

Abstract: OBJECTIVE：To investigate the expression of tonsoku-like DNA repair protein (TONSL) in esophageal carcinoma and its effect and mechanism on the proliferation of esophageal squamous cell carcinoma. METHODS：Databases such as cBioPortal，GEPIA and PRIDE were used to analyze changes in TONSL genome copy number and its transcription and translation levels in esophageal cancer. The expression of TONSL in esophageal squamous cell carcinoma and normal esophageal tissues was detected by immunohistochemistry. Small interfering RNA (siRNA) was used to construct a TONSL knockdown esophageal squamous cell model. The effect of TONSL knockdown on the proliferation of esophageal squamous cell carcinoma cells was studied by colony formation assay and EdU assay，while the changes of phosphorylated activation levels of ATM serine/threonine kinase (ATM) and checkpoint kinase 2 (CHK2)，two DNA damage repair related marker proteins in esophageal squamous cell carcinoma cells was detected by Western blot. RESULTS：Compared with normal esophageal tissue，copy number amplification of TONSL was common in esophageal cancer，and its mRNA and protein levels in esophageal cancer were up-regulated compared with those in normal esophageal tissues (P<0.05)，and high TONSL expression was associated with poor prognosis of patients with esophageal carcinoma (P<0.05). The results of immunohistochemistry also showed that TONSL was up-regulated in esophageal squamous cell carcinoma. The results of colony formation assay and EdU assay showed that knockdown of TONSL inhibited the proliferation of esophageal squamous cell carcinoma cells (P<0.05). Moreover，TONSL knockdown induced up-regulation of the phosphorylation of ATM serine/threonine kinase (ATM) and checkpoint kinase 2 (CHK2) in esophageal squamous cell carcinoma cells. CONCLUSION：TONSL was up-regulated in esophageal squamous cell carcinoma and promoted the proliferation of esophageal squamous cell carcinoma by participating in DNA damage repair.

Key words: esophageal squamous cell carcinomar, TONSL, cell proliferation, DNA damage repair

中图分类号:

R735.1

郑雅琪, 赵子婷, 潘德渊, 刘禄鑫, 许秀娥, 廖连娣, 王少洪, 李恩民, 许丽艳. TONSL在食管癌中的表达及其影响食管鳞癌细胞增殖的机制[J]. 癌变·畸变·突变, 2023, 35(6): 412-419.

ZHENG Yaqi, ZHAO Ziting, PAN Deyuan, LIU Luxin, XU Xiue, LIAO Liandi, WANG Shaohong, LI Enmin, XU Liyan. The expression of tonsoku-like DNA repair protein in esophageal carcinoma and its effect on the proliferation of esophageal squamous cell carcinoma[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2023, 35(6): 412-419.

参考文献

[1] CHU L Y, PENG Y H, WENG X F, et al. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma[J]. World J Gastroenterol, 2020, 26(15):1708-1725.
[2] LIU W, XIE L, HE Y H, et al. Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting[J]. Nat Commun, 2021, 12(1):4961.
[3] SMYTH E C, LAGERGREN J, FITZGERALD R C, et al. Oesophageal cancer[J]. Nat Rev Dis Primers, 2017, 3:17048.
[4] BANDLA S, PENNATHUR A, LUKETICH J D, et al. Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma[J]. Ann Thorac Surg, 2012, 93(4):1101-1106.
[5] GUPTA B, KUMAR N. Worldwide incidence, mortality and time trends for cancer of the oesophagus[J]. Eur J Cancer Prev, 2017, 26(2):107-118.
[6] RUSTGI A K, EL-SERAG H B. Esophageal carcinoma[J]. N Engl J Med, 2014, 371(26):2499-2509.
[7] RAY P, ZHANG D H, ELIAS J A, et al. Cloning of a differentially expressed I kappa B-related protein[J]. J Biol Chem, 1995, 270(18):10680-10685.
[8] NORMAN D A, BARTON P J. Isolation, sequence, and chromosomal localisation of the human IkappaBR gene (NFKBIL2)[J]. Ann Hum Genet, 2000, 64(Pt 1):15-23.
[9] GUYOMARC'H S, VERNOUX T, TRAAS J, et al. MGOUN3, an Arabidopsis gene with TetratricoPeptide-Repeat-related motifs, regulates meristem cellular organization[J]. J Exp Bot, 2004, 55(397):673-684.
[10] SUZUKI T, INAGAKI S, NAKAJIMA S, et al. A novel Arabidopsis gene TONSOKU is required for proper cell arrangement in root and shoot apical meristems[J]. Plant J, 2004, 38(4):673-684.
[11] TAKEDA S, TADELE Z, HOFMANN I, et al. BRU1, a novel link between responses to DNA damage and epigenetic gene silencing in Arabidopsis[J]. Genes Dev, 2004, 18(7):782-793.
[12] DURO E, LUNDIN C, ASK K, et al. Identification of the MMS22L-TONSL complex that promotes homologous recombination[J]. Mol Cell, 2010, 40(4):632-644.
[13] CHANG H R, JUNG E, CHO S, et al. Targeting non-oncogene addiction for cancer therapy[J]. Biomolecules, 2021, 11(2):129.
[14] YU B, DING Y M, LIAO X F, et al. Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma[J]. Pathol Res Pract, 2019, 215(5):939-945.
[15] NGUYEN M H, UEDA K, NAKAMURA Y, et al. Identification of a novel oncogene, MMS22L, involved in lung and esophageal carcinogenesis[J]. Int J Oncol, 2012, 41(4):1285-1296.
[16] CUI X B, SHEN Y Y, JIN T T, et al. SLC39A6:a potential target for diagnosis and therapy of esophageal carcinoma[J]. J Transl Med, 2015, 13:321.
[17] CERAMI E, GAO J J, DOGRUSOZ U, et al. The cBio cancer genomics portal:an open platform for exploring multidimensional cancer genomics data[J]. Cancer Discov, 2012, 2(5):401-404.
[18] GAO J J, AKSOY B A, DOGRUSOZ U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal[J]. Sci Signal, 2013, 6(269):pl1.
[19] TANG Z F, LI C W, KANG B X, et al. GEPIA:a web server for cancer and normal gene expression profiling and interactive analyses[J]. Nucleic Acids Res, 2017, 45(W1):W98-W102.
[20] PIWKO W, OLMA M H, HELD M, et al. RNAi-based screening identifies the Mms22L-Nfkbil2 complex as a novel regulator of DNA replication in human cells[J]. EMBO J, 2010, 29(24):4210-4222.
[21] PIWKO W, MLEJNKOVA L J, MUTREJA K, et al. The MMS22L-TONSL heterodimer directly promotes RAD51-dependent recombination upon replication stress[J]. EMBO J, 2016, 35(23):2584-2601.
[22] ALLUM W H, STENNING S P, BANCEWICZ J, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer[J]. J Clin Oncol, 2009, 27(30):5062-5067.
[23] GERTLER R, STEIN H J, LANGER R, et al. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction:evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system[J]. Ann Surg, 2011, 253(4):689-698.
[24] FERLAY J, SHIN H R, BRAY F, et al. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12):2893-2917.
[25] JEMAL A, BRAY F, CENTER M M, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
[26] PENNATHUR A, GIBSON M K, JOBE B A, et al. Oesophageal carcinoma[J]. Lancet, 2013, 381(9864):400-412.
[27] CAMPOS E I, SMITS A H, KANG Y H, et al. Analysis of the histone H3.1 interactome:a suitable chaperone for the right event[J]. Mol Cell, 2015, 60(4):697-709.
[28] FENG W, WU H, CHAN L N, et al. The Par-3 NTD adopts a PB1-like structure required for Par-3 oligomerization and membrane localization[J]. EMBO J, 2007, 26(11):2786-2796.
[29] HOU Y X, HU J Y, ZHOU L J, et al. Integrative analysis of methylation and copy number variations of prostate adenocarcinoma based on weighted gene co-expression network analysis[J]. Front Oncol, 2021, 11:647253.
[30] KHATPE A S, DIRKS R, BHAT-NAKSHATRI P, et al. TONSL is an immortalizing oncogene and a therapeutic target in breast cancer[J]. Cancer Res, 2023, 83(8):1345-1360.
[31] LEE H N, HA S, CHOI S, et al. Oncogenic impact of TONSL, a homologous recombination repair protein at the replication fork, in cancer stem cells[J]. Int J Mol Sci, 2023, 24(11):9530.
[32] SAREDI G, HUANG H D, HAMMOND C M, et al. H4K20me0 marks post-replicative chromatin and recruits the TONSL-MMS22L DNA repair complex[J]. Nature, 2016, 534(7609):714-718.
[33] DAVARINEJAD H, HUANG Y C, MERMAZ B, et al. The histone H3.1 variant regulates TONSOKU-mediated DNA repair during replication[J]. Science, 2022, 375(6586):1281-1286.

TONSL在食管癌中的表达及其影响食管鳞癌细胞增殖的机制

The expression of tonsoku-like DNA repair protein in esophageal carcinoma and its effect on the proliferation of esophageal squamous cell carcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王意浓, 刘国政, 谢观超, 冯丹, 李赛, 蔡岩, 张钰, 王明荣, 郝佳洁. 敲低膜联蛋白A2对食管鳞癌细胞恶性表型的抑制作用[J]. 癌变·畸变·突变, 2023, 35(6): 445-451.
[2]	高榴, 禹莉. 线粒体转录因子A在肿瘤发生发展中作用的研究进展[J]. 癌变·畸变·突变, 2023, 35(6): 485-488.
[3]	武慧慧, 耿淑慧, 郭志涛, 孟祥宁, 朱静. 染色体外环状DNA的研究进展[J]. 癌变·畸变·突变, 2023, 35(5): 392-397.
[4]	刘瑞雪, 张力为. 腺苷酸活化蛋白激酶在哈萨克族食管鳞癌组织中的表达及意义[J]. 癌变·畸变·突变, 2023, 35(4): 285-291.
[5]	杜威, 李仁燕, 杨丹. 细胞分裂周期相关因子2的研究进展[J]. 癌变·畸变·突变, 2023, 35(4): 320-324.
[6]	史建红, 陈丁雄, 卢晓童, 郝佳洁, 蔡岩, 王明荣, 张钰. ICG-001对食管鳞癌细胞增殖的抑制作用及其分子机制[J]. 癌变·畸变·突变, 2023, 35(3): 187-191,196.
[7]	付静, 刘清, 于海叶, 王磊. miR-495通过抑制RNF113A的表达调控食管鳞癌细胞恶性表型[J]. 癌变·畸变·突变, 2023, 35(3): 202-208,214.
[8]	冯丹, 范志露, 王意浓, 李赛, 郭婧, 蔡岩, 张钰, 魏文强, 王明荣, 郝佳洁. P4HA2通过激活EGFR/AKT/S6信号通路促进食管鳞癌细胞的增殖[J]. 癌变·畸变·突变, 2023, 35(2): 87-94,101.
[9]	李子垚, 张海平, 买地尼也提·尼亚孜, 居来提·艾尼瓦尔, 张力为, 伊地力斯·阿吾提. Cystatin 6蛋白在哈萨克族食管鳞癌组织中的表达及其意义[J]. 癌变·畸变·突变, 2022, 34(6): 429-433,438.
[10]	张军军, 梁乐平. PTEN C末端对鼻咽癌细胞迁移及增殖能力的影响[J]. 癌变·畸变·突变, 2022, 34(6): 434-438.
[11]	毕佳欣, 王晓雪, 赵若晗, 韩旭, 宋洁. 着丝粒蛋白T在乳腺癌中表达及其启动子区变异的研究[J]. 癌变·畸变·突变, 2022, 34(5): 327-334.
[12]	张月, 王耀一, 武雪亮, 张志生, 杨修明, 姜洋, 乔志飞, 梁晚平, 薛军. ¹²⁵I粒子联合AZD1152对三阴性乳腺癌细胞增殖和凋亡的影响[J]. 癌变·畸变·突变, 2022, 34(4): 295-299,306.
[13]	王蕊, 刘颖, 吴娟, 纪晓坤, 马阳, 郭晓, 杜芸. 胸腔积液肺腺癌细胞中CXCR4、Ki67、MDM2、N-cadherin的表达及其与EGFR突变状态的关系[J]. 癌变·畸变·突变, 2022, 34(2): 114-118.
[14]	赵岩, 孙震晓. 二甲双胍抑制人MDA-MB-231细胞增殖及迁移的体外实验研究[J]. 癌变·畸变·突变, 2022, 34(1): 35-39.
[15]	杨兴肖, 张雪原, 邹乃祎, 单保恩, 马鸣, 祝淑钗. 干扰HMGB1基因表达对食管鳞癌细胞侵袭迁移及放射敏感性的影响[J]. 癌变·畸变·突变, 2021, 33(5): 327-333.